BEL Shares Dip Ahead of Q1 FY25 Results — Is It a Buying Opportunity? Revenue miss but operationally strong numbers!
Earning Preview
Mitesh Patel : Journey of Chemical Engineer to Successful Option Trader: From Loss 4-5 Lakh to Profit in Crore.
“FNO game is for Big Player,Not for small players”
TCS to Cut 2% (12,000) Manpower :Who will the job cuts affect? Support for Affected Employees
The job cuts will primarily be targeted towards the middle and senior management roles of the company.
Lost the Money in FY 2025: Here are take away for Retail and FNO Traders.
SEBI FY25 Study: Over 91% of F&O Traders Lost Money
Lost the Money in FY 2025: Here are take away for Retail and FNO Traders. Read Post »
Nifty IT index dropped nearly 2%,:Shows weakness after Q1 Results
Investors are shifting focus to banking, auto, and FMCG, which are showing stronger earnings and resilience
Nifty IT index dropped nearly 2%,:Shows weakness after Q1 Results Read Post »
Axis Bank, Wipro, Jio Financial, LTI, HDFC AMC Mindtreeand many more Set to Release June Quarter Numbers Today
Axis Bank, Wipro, Jio Financial, LTI, HDFC AMC Mindtree
Angel One leading stock broking firm going to to declare the Results Today
Q1 FY25 Results to Be Announced Today – Key Metrics to Watch is Margin Expansion & Revenue Growth Stock is
Angel One leading stock broking firm going to to declare the Results Today Read Post »
Swiggy share price climbs more than 1.5 % in Mixed market, is it a stock to buy?
After ElaraSecurities initiates ‘accumulate’ rating on Swiggy with target price of Rs 450, Stock climbed up 1.5% early morning sessions. As per the research report
Swiggy share price climbs more than 1.5 % in Mixed market, is it a stock to buy? Read Post »
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S
As a part of agreement, Incyte has granted to Sun a limited, non-exclusive license to U.S. Patent and certainother related patents with respect to oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications including alopecia areata, in the U.S.
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S Read Post »